Earnings
Covidien To Buy VNUS Medical For $440 Million
NEW YORK (AP) — Covidien Ltd. said Friday it agreed to buy smaller medical device maker VNUS Medical Technologies Inc. for $440 million in cash.
The medical device maker and diversified health care company is valuing VNUS at $29 per share, a 36-percent premium to that stock's Thursday closing price. Covidien said it expects the deal to be complete by June 30. San Jose, Calif.-based VNUS makes products that treat varicose veins and venous reflux disease, a circulatory condition that causes blood to pool in the veins of the leg. That can cause swollen veins and discolored skin. Covidien said it is expanding its vascular business by buying VNUS, and it will make VNUS part of its vascular product line. VNUS reported $101.2 million in revenue in 2008, and expects $107 million to $111 million this year. Covidien, which is based in Dublin, said the costs of the purchase will reduce its 2009 profit by a small amount. In premarket trading, VNUS shares jumped $7.38, or 34.6 percent, to $28.70. The stock closed at $21.32 on Thursday, and has traded between $10.81 and $24.44 over the last year. Covidien shares finished at $34.20 Thursday.TheStreet Premium Services
Jim Cramer's Action Alerts PLUS:
Trade right alongside a Wall Street pro — enjoy access to his Charitable Trust portfolio and be sent trade alerts BEFORE he makes a move. Learn More
OptionsProfits:
Get 50+ trade ideas a week from the industry's top options experts. Plus — exclusive commentary on market trends and essential trading tools. Learn More
Real Money:
Our team of professional Wall Street Pros — including Jim Cramer, Doug Kass, and Nicholas Vardy — delivers intelligent analysis, timely trade ideas, and colorful commentary. Learn More
Stocks Under $10:
Break into the market with small- and mid-cap stocks... all $10 or less! David Peltier tells you exactly which low-priced stocks he's buying and selling. Learn MoreTo begin commenting right away, you can log in below using your Disqus, Facebook, Twitter, OpenID or Yahoo login credentials. Alternatively, you can post a comment as a "guest" just by entering an email address. Your use of the commenting tool is subject to multiple terms of service/use and privacy policies - see here for more details.
blog comments powered by Disqus
| Dow Jones | S&P 500 | NASDAQ | 10-Year Note |
|
|---|---|---|---|---|
| 12,393.45 | 1,310.33 | 2,827.34 | 15.81 |
Oil *
101.78
|
|
DOWN
26.41 |
DOWN
2.99 |
DOWN
10.02 |
DOWN
0.44 |
10 Yr
1.58%
SPDR Gold
151.62
|
|
-0.21%
|
-0.23%
|
-0.35%
|
-2.71%
|
Data delayed 20 minutes |
Connect with TheStreet